TRUSTED ADVICE. TRUSTED SOURCES. · Combining the Quartic platform with its proven approach and...
4
© 2019 Axendia, Inc. TRUSTED ADVICE. TRUSTED SOURCES. / ARTIFICIAL INTELLIGENCE CAN MAKE PHARMACEUTICAL COMPANIES MORE COMPETITIVE QUARTIC.AI BRIEFING NOTE By: Eric M. Luyer, Industry Research Analyst INTRODUCTION Recently Axendia was briefed by the senior executive team of Quartic.ai, based in San Jose, CA, US. Quartic.ai was founded in 2017 by veterans in process automation, manufacturing, and reliability in conjunction with data scientists to optimize the practical use of information through Artificial Intelligence (AI) deployment. The company had been recognized last year as the fastest growing technology leader in industrial AI by CIO Review Magazine. The mission of Quartic.ai is to enable subject matter experts (SME) to help solve manufacturing problems by using AI. “We look at this as becoming another tool in their tool-belt of problem-solving. What we're building enables the SMEs to build their solutions with AI”, said Rajiv Anand the CEO of Quartic.ai. According to Rajiv Anand, their vision and mandate is not to grow their business through providing services, but by providing the technology. Their technology is a complete “smart industry platform” to support process- and pharma manufacturing industries via digital transformation using the concepts of the Industrial Internet of Things (IIoT) and AI. Combining the Quartic platform with its proven approach and expertise, manufacturers are now able to extract more value from their legacy infrastructure and build Industry 4.0 factory capabilities. This will help accelerate the decision-making process in an organization using their IIoT and AI deployment capabilities. It will also increase productivity significantly, improve operational performance and position the company as more competitive. “We looked at where most of the challenges in the industry are right now. They are around lack of talent, or better said: lack of data science talent. We're solving that problem by building AI for the subject matter expert, which is based on a lot of automation of machine learning, zero-code, etc.…The other bigger challenge is the integration of all your legacy data. Those are the two focus areas, and that's how our technology platform is structured: eXponence is the intelligence engine, and Illuminator is the data engine”, commented Rajiv Anand.
Transcript of TRUSTED ADVICE. TRUSTED SOURCES. · Combining the Quartic platform with its proven approach and...
©2019Axendia,Inc.
TRUSTED ADVICE. TRUSTED SOURCES.
/
ARTIFICIALINTELLIGENCECANMAKEPHARMACEUTICALCOMPANIESMORECOMPETITIVEQUARTIC.AIBRIEFINGNOTE
By:EricM.Luyer,IndustryResearchAnalyst INTRODUCTION RecentlyAxendiawasbriefedbytheseniorexecutiveteamofQuartic.ai,basedinSanJose,CA,US.Quartic.aiwasfoundedin2017byveteransinprocessautomation,manufacturing,andreliabilityinconjunctionwithdatascientiststooptimizethepracticaluseofinformationthroughArtificialIntelligence(AI)deployment.ThecompanyhadbeenrecognizedlastyearasthefastestgrowingtechnologyleaderinindustrialAIbyCIOReviewMagazine.ThemissionofQuartic.aiistoenablesubjectmatterexperts(SME)tohelpsolvemanufacturingproblemsbyusingAI.“Welookatthisasbecominganothertoolintheirtool-beltofproblem-solving.Whatwe'rebuildingenablestheSMEstobuildtheirsolutionswithAI”,saidRajivAnandtheCEOofQuartic.ai.AccordingtoRajivAnand,theirvisionandmandateisnottogrowtheirbusinessthroughprovidingservices,butbyprovidingthetechnology.Theirtechnologyisacomplete“smartindustryplatform”tosupportprocess-andpharmamanufacturingindustriesviadigitaltransformationusingtheconceptsoftheIndustrialInternetofThings(IIoT)andAI.CombiningtheQuarticplatformwithitsprovenapproachandexpertise,manufacturersarenowabletoextractmorevaluefromtheirlegacyinfrastructureandbuildIndustry4.0factorycapabilities.Thiswillhelpacceleratethedecision-makingprocessinanorganizationusingtheirIIoTandAIdeploymentcapabilities.Itwillalsoincreaseproductivitysignificantly,improveoperationalperformanceandpositionthecompanyasmorecompetitive.“Welookedatwheremostofthechallengesintheindustryarerightnow.Theyarearoundlackoftalent,orbettersaid:lackofdatasciencetalent.We'resolvingthatproblembybuildingAIforthesubjectmatterexpert,whichisbasedonalotofautomationofmachinelearning,zero-code,etc.…Theotherbiggerchallengeistheintegrationofallyourlegacydata.Thosearethetwofocusareas,andthat'showourtechnologyplatformisstructured:eXponenceistheintelligenceengine,andIlluminatoristhedataengine”,commentedRajivAnand.
©2019Axendia,Inc.2
QUARTIC.AIBRIEFINGNOTEMACHINE LEARNING PLATFORMS ThetechnologyplatformautomatestheimplementationofMachineLearning,butallowstheSMEtodeterminethefeaturesandaspectsthatrepresenttheproblemtobeusedtobuildthemodels.Thisallowsuserstounderstandandexplaintheoutputofmodelsateverystep–building,testing,validationanddeployment.
“OureXponenceenginereallyfocusesontheautomatedmachinelearningdevelopmentandautomatedanalyticsforcriticalequipmentandprocesses.Whatthisletsthem[SMEs]doisnotonlybuildintelligencewithouthavingthedeepdatascienceknowledge,butalsodeploytheintelligence,beingabletohavetheseindividualmodelsmonitortheirprocesses,monitortheirequipment,providefeedback,provideinsights,andthenturnaroundandmakedecisionsandchanges,canimprovetheirprocesses.IlluminatorTMprovidesafullyintegratedcontextualdatapipelineforexpertusersanddata-scientiststobuildAIapplicationswithtoolsandlibrariesoftheirchoice”,remarkedVinodhRodrigues,Manager,IndustrySolutionsofQuartic.ai.
Source: Quartic.ai
©2019Axendia,Inc.3
QUARTIC.AIBRIEFINGNOTETalkingabouttheirmissionandvision,LarryTaber,VicePresidentLifeSciencesIndustryofQuartic.aiadded:“Ifwearespeakingtoseniorexecutives,ourintentistodrivemanufacturinginnovationtoanyextentpossibleontheexistingassets,andtospeednewproductstomarket.Webelievethat,bythedesignoftheplatform,we'regoingtolowertheactivationenergyandthedirectinvestmentneededtobringmultiplefunctionsfrompharmaaroundthetablebyuseofMachineLearningandAI”. IN BRIEF Thecompany’sfocusisonlate-stagemoleculesandproducts,specificallyonlate-stagedevelopment,technologytransfer,andcommercialization.Theirintentandbusinessstrategyistohavethetechnologyplatformassociatedwiththecontrolstrategiesforproductsthroughouttheirlifecycle.Fromamarketperspectiveandobservingcurrentdriversinthepharmaindustry,thesesolutionsarewellplacedconsideringtheshifttobiologics,morecomplexmolecules,andmoreinnovativemanufacturingplatforms.Alsoinviewofadvanceddevelopmentsthataretakingplacewithplatform-basedapproachesforrapidtechnologytransferandrapidproductdevelopmentaswellascommerciallaunches,therearemorebusinessopportunitiesespeciallyforsmaller-scaleoperations.Usingthesenewtechnologiesandplatform,thebenefitsaregettingclearer:First,onceyouhaveabetterunderstandingofhowcurrentprocessesareworkingandhavethesealsodigitallyavailable(inadigitaltwin),youthencanmakechangesdigitallyinavirtual
Source: Quartic.ai
©2019Axendia,Inc.4
QUARTIC.AIBRIEFINGNOTEenvironmentbeforeactuallymovethemintotesting.Thisalsohelpspredictchangesinfollowingreleases.Secondly,itassistsinrespondingtoquestionsaroundregulatorysupportordata-modelingandvalidation:e.g.howdoyouknowyourmodelisrobust,orhowcanyoutestyourvalidationappropriately,orwhatkindofrisk-basedmethodscanyouadopt?Moregenerally,thissolutionhighlycontributestoacompany’svaluepropositionusingsophisticatedtechnologysuchasMachineLearningandArtificialIntelligence.Itallowsforchangingtheproductionanddesignmind-setfromareactivedesigntoamoreproactivedesign,movingbusinessprocessesintoafuture-perspective,tryingtofindthebestandoptimizedprocessandresultpossible. ThisBriefwaswrittenbyAxendia,Inc.TheopinionsandanalysisexpressedinthisBriefreflectthejudgment of Axendia at the time of publication and are subject to change without notice.Informationcontainedinthisdocumentiscurrentasofpublicationdate. Informationcitedisnotwarranted by Axendia but has been obtained through a valid research methodology. Thisdocumentisnotintendedtoendorseanycompanyorproductandshouldnotbeattributedassuch. AboutAxendia:Axendia is a leading analyst and strategic advisory firm that focuses exclusively on the Life-Sciences markets. Since 2005, Industry stakeholders and regulators have relied on Axendia for trusted advice on Business, Regulatory and Technology issues and trends based on trusted sources. Axendia serves the entire Life-Science ecosystem ranging from start-ups to Fortune 100 companies including: Life-Science Organization, Technology & Service Providers, and Regulatory Agencies. Axendia professionals offer a unique combination of deep hands-on industry experience coupled with forward thinking insights. We contribute to our client’s success by providing long-range visibility and helping them navigate the increasingly complex landscape. Formoreinformation,[email protected]
ReadAxendia’sblog:Life-SciencePanoramaathttp://LSP.axendia.com
FollowusonTwitterattwitter.com/axendiaandLinkedInatlinkedin.com/company/axendia-inc.
©2019Axendia,Inc.AllRightsReserved.ThispublicationiscopyrightedbyAxendiaInc.andprotectedbyUnitedStatescopyrightlawsandinternationaltreaties.ThisdocumentmaynotbereproducedorpostedonanotherwebsitewithoutpriorwrittenconsentfromAxendia.Unauthorizedreproductionofthispublicationoranyportionofitbyotherpartiesmayresultinseverecivilandcriminalpenalties,andwillbeprosecutedtothemaximumextentnecessarytoprotecttherightsofthepublisher.
PublishedJune2019
